Global menu

Our global pages

Close

Eversheds Sutherland advises Otsuka Novel Products GmbH on strategic global collaboration

  • Germany
  • Global
  • United Kingdom

    02-04-2020

    Eversheds Sutherland has advised Otsuka Novel Products GmbH on a strategic global collaboration to develop transformative treatment regimens for tuberculosis with the Bill & Melinda Gates Medical Research Institute and the Bill & Melinda Gates Foundation and Evotec, GSK, Johnson & Johnson and Otsuka Pharmaceutical Co., Ltd., based in Japan.

    Eversheds Sutherland provided advice on all aspects of the matter, from the early stage of setting up a term sheet between the different members, to all the negotiations on complex regulatory and intellectual property law issues on a global scale, addressing the different needs and demands of philanthropic, non-profit and private sector organizations.

    Tobias Maier, co-head of the health and life sciences sector and a Partner in Eversheds Sutherland’s IP and Commercial practice led the team, with support from Nils Müller, Principal Associate, and Magdalena Kotyrba, Senior Associate (all Munich).

    Tobias Maier commented:

    “We are delighted to have helped Otsuka Novel Products GmbH to be part of  a ground-breaking collaboration with the other collaborators to accelerate the development of novel TB treatment regimens.”

    The complete project was driven by the senior management and senior legal in-house teams of the respective parties, see here.

    For more information contact

    Dr. Tobias Maier, Partner

    Disclaimer

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back

    Print Friendly and PDF
    Register to receive regular updates via email.
    Print Friendly and PDF

    © Eversheds Sutherland 2020. All rights reserved. Eversheds Sutherland is a global provider of legal services operating through various separate and distinct legal entities.

    Eversheds Sutherland is the name and brand under which the members of Eversheds Sutherland Limited (Eversheds Sutherland (International) LLP and Eversheds Sutherland (US) LLP) and their respective controlled, managed and affiliated firms and the members of Eversheds Sutherland (Europe) Limited (each an "Eversheds Sutherland Entity" and together the "Eversheds Sutherland Entities") provide legal or other services to clients around the world. Eversheds Sutherland Entities are constituted and regulated in accordance with relevant local regulatory and legal requirements and operate in accordance with their locally registered names. The use of the name Eversheds Sutherland, is for description purposes only and does not imply that the Eversheds Sutherland Entities are in a partnership or are part of a global LLP. The responsibility for the provision of services to the client is defined in the terms of engagement between the instructed firm and the client.